Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Beijing Beilu Pharma Raises 67 Million RMB

publication date: Aug 26, 2008

Beijing Beilu Pharmaceutical Co., Ltd., a company that is focused on traditional Chinese medicines, raised 66.6 million RMB ($9.7 million) by issuing 12.5 million shares to seven investors. The largest block went to Infotech Pacific Ventures, which took down 7.5 million shares for 40 million RMB ($5.8 million). After the refinancing, Infotech was the fourth largest shareholder in Beilu, owning almost 15% of the total shares outstanding. The funding gives the company a post-money valuation of $39 million. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital